Viewing Study NCT05462756


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-06-02 @ 12:21 PM
Study NCT ID: NCT05462756
Status: COMPLETED
Last Update Posted: 2025-04-27
First Post: 2022-07-14
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Insulin Efsitora Alfa (LY3209590) as a Weekly Basal Insulin Compared to Insulin Glargine in Adult Participants With Type 2 Diabetes on Multiple Daily Injections
Sponsor: Eli Lilly and Company
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes View
None Type 2 Diabetes Treated With Insulin View
Keywords: